Morphologic features of lung adenocarcinomas in relation to responsiveness to epidermal growth factor receptor (EGFR) inhibitors and EGFR mutational status

被引：0
|
作者：
Zakowski, MF [1 ]
Hussian, S [1 ]
Pao, W [1 ]
Miller, VA [1 ]
Kris, MG [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1493
引用
收藏
页码：321A / 321A
页数：1
相关论文
共 50 条
  • [21] Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report
    Takuwa, Teruhisa
    Tanaka, Fumihiro
    Yoneda, Kazue
    Torii, Ikuko
    Hashimoto, Masaki
    Okumura, Yoshitomo
    Matsumoto, Seiji
    Kondo, Nobuyuki
    Hasegawa, Seiki
    LUNG CANCER, 2010, 68 (03) : 498 - 500
  • [22] Pharmacogenomics of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
    Jimeno, Antonio
    Hidalgo, Manuel
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1766 (02): : 217 - 229
  • [23] Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
    Chan, David Lok Hang
    Segelov, Eva
    Wong, Rachel S. H.
    Smith, Annabel
    Herbertson, Rebecca A.
    Li, Bob T.
    Tebbutt, Niall
    Price, Timothy
    Pavlakis, Nick
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (06):
  • [24] Foreword: Epidermal Growth Factor Receptor (EGFR) Inhibitors and Cancer Therapeutics
    Dicker, AP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 898 - 898
  • [25] Sweet syndrome induced by epidermal growth factor receptor (EGFR) inhibitors
    Cheung, Christina M. T.
    Li, Joshua J. X.
    Ip, Edric C. C.
    Chan, Agnes W. S.
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2022, 88 (05): : 664 - 666
  • [26] Epidermal growth factor receptor (EGFR) mutations in lung carcinomas are associated with distinct cytomorphological features
    Brachtel, EF
    Iafrate, AJ
    Mark, EJ
    Deshpande, V
    LABORATORY INVESTIGATION, 2006, 86 : 54A - 54A
  • [27] Role of Epidermal Growth Factor Receptor (EGFR) Inhibitors and Radiation in the Management of Brain Metastases from EGFR Mutant Lung Cancers
    Khandekar, Melin J.
    Piotrowska, Zofia
    Willers, Henning
    Sequist, Lecia V.
    ONCOLOGIST, 2018, 23 (09): : 1054 - 1062
  • [28] Epidermal growth factor receptor (EGFR) mutations in lung carcinomas are associated with distinct cytomorphological features
    Brachtel, EF
    Iafrate, AJ
    Mark, EJ
    Deshpande, V
    MODERN PATHOLOGY, 2006, 19 : 54A - 54A
  • [29] EXON 20 MUTATIONS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) IN LUNG ADENOCARCINOMAS: CLINICOPATHOLOGIC FACTORS AND RESPONSE TO THERAPY
    Naidoo, J.
    Sima, C. S.
    Hellmann, M. D.
    Arcila, M. E.
    Rizvi, N. A.
    Yu, H. A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S40 - S40
  • [30] Microarray Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status
    LaFrance, D. R.
    Lowery-Nordberg, M.
    LABORATORY INVESTIGATION, 2010, 90 : 434A - 434A
12345